MRSA pneumonia: Better outcome through continuous infusion of vancomycin?

被引：16

作者：

Blot, S ^{[1
]}

机构：

[1] State Univ Ghent Hosp, Dept Intens Care, B-9000 Ghent, Belgium

来源：

CRITICAL CARE MEDICINE | 2005年 / 33卷 / 09期

关键词：

ventilator-associated pneumonia; methicillin-resistant Staphylococcus aureus; mortality; outcome; vancomycin; intensive care unit;

D O I：

10.1097/01.CCM.0000178288.70057.47

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：2127 / 2128

页数：2

共 15 条

[1] Early detection of systemic infections
Blot, S
Vandewoude, K
[J]. ACTA CLINICA BELGICA, 2004, 59 (01) : 20 - 23
[2] Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus
Blot, SI
Vandewoude, KH
Hoste, EA
Colardyn, FA
[J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) : 2229 - 2235
[3] Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia
Byl, B
Clevenbergh, P
Jacobs, F
Struelens, MJ
Zech, F
Kentos, A
Thys, JP
[J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 60 - 66
[4] Ventilator-associated pneumonia
Chastre, J
Fagon, JY
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 867 - 903
[5] Cruciani M, 1996, J ANTIMICROB CHEMOTH, V38, P865
[6] Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock
De Paepe, P
Belpaire, FM
Buylaert, WA
[J]. CLINICAL PHARMACOKINETICS, 2002, 41 (14) : 1135 - 1151
[7] Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection
Di Filippo, A
De Gaudio, AR
Novelli, A
Paternostro, E
Pelagatti, C
Livi, P
Novelli, GP
[J]. CHEMOTHERAPY, 1998, 44 (01) : 63 - 68
[8] The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient
Heyland, DK
Cook, DJ
Griffith, L
Keenan, SP
Brun-Buisson, C
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) : 1249 - 1256
[9] THE IMPORTANCE OF PHARMACOKINETIC-PHARMACODYNAMIC SURROGATE MARKERS TO OUTCOME - FOCUS ON ANTIBACTERIAL AGENTS
HYATT, JM
MCKINNON, PS
ZIMMER, GS
SCHENTAG, JJ
[J]. CLINICAL PHARMACOKINETICS, 1995, 28 (02) : 143 - 160
[10] Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
James, JK
Palmer, SM
Levine, DP
Rybak, MJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) : 696 - 700

← 1 2 →